Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
166 hedge funds and large institutions have $597M invested in Silk Road Medical, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 74 increasing their positions, 52 reducing their positions, and 36 closing their positions.
70% more call options, than puts
Call options by funds: $8.44M | Put options by funds: $4.96M
42% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 52
4% less funds holding
Funds holding: 173 → 166 (-7)
19% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 36
58% less capital invested
Capital invested by funds: $1.42B → $597M (-$824M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$14.9M |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
+$14.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$12.1M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$9.59M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$7.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$50.9M |
| 2 |
FAM
Fred Alger Management
New York
|
-$40.3M |
| 3 |
DM
Deerfield Management
New York
|
-$36.8M |
| 4 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$18.7M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$12.9M |
SILK Hedge Fund Activity: Q3 2023 in Review
166 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2023, worth a combined $597M — down 58% from $1.42B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of SILK and 29 opened new positions — a net loss of 7 holders — while 52 trimmed existing stakes and 74 added.
The largest buyer was Granite Investment Partners, opening a new position worth an estimated $14.9M. The largest seller was AllianceBernstein, cutting an estimated $50.9M.
- 166 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2023, down from 173 in Q2 2023.
- Funds reported $597M of Silk Road Medical, Inc. Common Stock stock for Q3 2023, down 58% quarter-over-quarter.
- 29 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2023 and 36 closed out, a net change of -7 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q3 2023 was Granite Investment Partners, an estimated $14.9M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q3 2023 was AllianceBernstein, an estimated $50.9M sold.
Based on aggregated 13F filings for Q3 2023.